| |
 |
Editorial [Hot Topic: Gold Derivatives as Anti-Cancer Agents (Guest Editor: Laura Rodriguez Raurell)]
 |
| |
|
pp.920-920 (1) Author: Laura Rodriguez Raurell |
| |
|
|
| |
|
Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
|
| |
|
pp.921-928 (8) Authors: Joao Carlos Lima, Laura Rodriguez |
| |
|
|
| |
|
Protein Targets for Anticancer Gold Compounds: Mechanistic Inferences
|
| |
|
pp.929-939 (11) Authors: Chiara Gabbiani, Luigi Messori |
| |
|
|
| |
|
Strategies for the Biological Evaluation of Gold Anticancer Agents
|
| |
|
pp.940-952 (13) Author: Simon P. Fricker |
| |
|
|
| |
|
Gold Nanostructures as Photothermal Therapy Agent for Cancer
|
| |
|
pp.953-964 (12) Authors: Jihye Choi, Jaemoon Yang, Eunji Jang, Jin-Suck Suh, Yong-Min Huh, Kwangyeol Lee, Seungjoo Haam |
| |
|
|
| |
|
Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
|
| |
|
pp.965-973 (9) Authors: Rachel A. Kudgus, Resham Bhattacharya, Priyabrata Mukherjee |
| |
|
|
| |
|
SMILES-based QSAR Approaches for Carcinogenicity and Anticancer Activity: Comparison of Correlation Weights for Identical SMILES Attributes
|
| |
|
pp.974-982 (9) Authors: Andrey A. Toropov, Alla P. Toropova, Emilio Benfenati, Giuseppina Gini, Danuta Leszczynska, Jerzy Leszczynski |
| |
|
|
| |
|
TEM8 Targeted Cancer Therapy
|
| |
|
pp.983-992 (10) Authors: Arthur E. Frankel, Carol Carter, Shu-Ru Kuo, Jung-Hee Woo, Jeremy Mauldin, Jen-Sing Liu |
| |
|
|
| |
|
Protein Kinase B/AKT and Focal Adhesion Kinase: Two Close Signaling Partners in Cancer
|
| |
|
pp.993-1002 (10) Authors: Shouye Wang, Marc D. Basson |
| |
|
|
